Abstract CN103
Background
Constipation is a common symptom in cancer patients undergoing chemotherapy, radiotherapy or opioids. There are no validated and reliable scales to measure constipation as a side effect in Turkey. The aim of this study was to test the validity and reliability of the Turkish version of the Constipation Assessment Scale.
Methods
The study is methodological research. The sample included 100 cancer patients in the oncology department of a public hospital who agreed to participate in the study. Data were collected between 1 May and 1 September 2023. The validity and reliability of the scale were assessed in three stages: translation, validity (content and construct validity) and reliability. The scale was translated using the back translation technique. The content validity index was 1.00. The Cronbach's alpha coefficient was 0.93. The scale showed a significant difference between the lower and upper groups (p<0.05). The scale was translated using the back translation technique.
Results
The content validity index of the scale was determined as 1.00. Cronbach's alpha coefficient was 0.93. The scale showed a significant difference between the lower and upper groups (p<0.05). The scale made fine distinctions. It was observed that the intraclass correlation coefficient values regarding the agreement between test-retest measurements were high, and there was no difference between test-retest values (p<0.05). It was observed that the fit statistics calculated by confirmatory factor analysis were in acceptable compliance with the predetermined factor structure of the scale. Standardized coefficients show that factor loadings are high. Standard errors were low and t values were significant.
Conclusions
The study concludes that the scale is appropriate for the Turkish population and will be a useful tool for professionals, researchers, and health professionals in future studies.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN23 - Development of multidisciplinary DigiCanTrain Digital Competence Framework for cancer care
Presenter: Heli Mikkonen
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN24 - Experience with the routine use of ePROMs in nurse and pharmacist-led telephone clinics for patients with prostate cancer
Presenter: Kate O'Connor
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN25 - Barriers and facilitators of optimal engagement with teleoncology for older cancer survivors: A rapid review of qualitative literature
Presenter: Carike Barnardo
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN33 - G-8 geriatric screening tool and geriatric nutritional risk index
Presenter: Mehmet Artac
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN34 - Suicide and digestive cancer: A systematic review
Presenter: Diana Lazar
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN35 - Screening recommendations for and outcomes of male patients (pts) with germline BRCA (gBRCA)
Presenter: Heba Mohamed
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN36 - Fasting in cancer patients during chemotherapy: A monocentric study
Presenter: Wala Ben Kridis
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN37 - Use of pictograms (picto) for outpatients treated for cancer and monitored by telehealth: A feasibility and proof of concept study
Presenter: Coralie Boiteau
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN38 - Risk of cardiovascular mortality among cancer survivors in the United States: The role of inflammation
Presenter: Peng Wang
Session: EONS Poster Display session
Resources:
Abstract
CN39 - Exploring the pleasure of eating within children undergoing chemotherapy
Presenter: Malek Khlif
Session: EONS Poster Display session
Resources:
Abstract
Slides